Skip to main content

Advertisement

SpringerLink
Log in

Reversible Posterior Leukoencephalopathy Syndrome Caused by Bevacizumab: Report of a Case

  • Case Report
  • Published:
Diseases of the Colon & Rectum

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Hinchey J, Chaves C, Appignani B, et al.. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.

    Article  PubMed  CAS  Google Scholar 

  2. Ozcan C, Wong SJ, Hari P. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980–2.

    Article  PubMed  Google Scholar 

  3. Glusker P, Recht L, Lane B. Reversible posterior leukoencephalopathy syndrome and bevacizumab. N Engl J Med 2006;354:980–2.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors thank A. M. van der Vliet, M.D., Ph.D., radiologist, Radboud University Medical Centre, Nijmegen, for evaluating the CT scan.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands

    Miriam Koopman M.D. & Cornelis J. A. Punt M.D., Ph.D.

  2. Slingeland Hospital, Doetinchem, The Netherlands

    Erik W. Muller M.D., Ph.D.

Authors
  1. Miriam Koopman M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erik W. Muller M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cornelis J. A. Punt M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cornelis J. A. Punt M.D., Ph.D..

Additional information

Supported by the Dutch Cancer Foundation grant no. CKTO 2002–07 and by unrestricted research grants from Merck-Serono, Roche and Sanofi-Aventis, The Netherlands.

About this article

Cite this article

Koopman, M., Muller, E.W. & Punt, C.J.A. Reversible Posterior Leukoencephalopathy Syndrome Caused by Bevacizumab: Report of a Case. Dis Colon Rectum 51, 1425–1426 (2008). https://doi.org/10.1007/s10350-008-9282-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10350-008-9282-8

Key words

Search

Navigation